Integrated analysis of copy number and loss of heterozygosity in primary breast carcinomas using high-density SNP array

International Journal of Oncology

Volumn 39, Issue 3, 2011, Pages 621-633

  Ching, Ho Ching ^a   Naidu, Rakesh ^b   Seong, Mun Kein ^a,c   Har, Yip Cheng ^a,c   Taib, Nur Aishah Mohd ^a,c  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b MONASH UNIVERSITY MALAYSIA   (Malaysia)

^c UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

Author keywords

Breast cancer; Copy number; Copy neutral loss of heterozygosity; Loss of heterozygosity; Single nucleotide polymorphism array

Indexed keywords

ALGORITHM; ARTICLE; BLOOD; BREAST CARCINOMA; CHROMOSOME; CHROMOSOME 14Q; CHROMOSOME 8P; CHROMOSOME 8Q; CONTROLLED STUDY; COPY NUMBER VARIATION; DNA EXTRACTION; FEMALE; HETEROZYGOSITY LOSS; HIDDEN MARKOV MODEL; HOSPITAL; HUMAN; HUMAN CELL; HUMAN TISSUE; HYBRIDIZATION; MALAYSIA; MICROARRAY ANALYSIS; PREVALENCE; PRIMARY TUMOR; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

BREAST NEOPLASMS; DNA COPY NUMBER VARIATIONS; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 79959966821     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1081     Document Type: Article

References (55)

1. Wang ZGC, Lin M, Wei LJ, et al: Loss of heterozygosity and its correlation with expression profiles in subclasses of invasive breast cancers. Cancer Res 64: 64-71, 2004. (Pubitemid 38114083)
2. Rennstam K, Ahlstedt-Soini M, Baldetorp B, et al: Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization. Cancer Res 63: 8861-8868, 2003. (Pubitemid 38064066)
3. Miyakis S and Spandidos DA: Allelic loss in breast cancer. Cancer Detect Prev 26: 426-434, 2002. (Pubitemid 36035372)
4. Zhou XF, Rao NP, Cole SW, Mok SC, Chen ZG and Wong DT Progress in concurrent analysis of loss of heterozygosity and comparative genomic hybridization utilizing high density single nucleotide polymorphism arrays. Cancer Genet Cytogenet 159: 53-57, 2005. (Pubitemid 40614724)
5. Stange DE, Radlwimmer B, Schubert F, et al: High-resolution genomic profiling reveals association of chromosomal aberrations on 1q and 16p with histologic and genetic subgroups of invasive breast cancer. Clin Cancer Res 12: 345-352, 2006. (Pubitemid 43166120)
6. Zudaire I, Odero MD, Caballero C, et al: Genomic imbalances detected by comparative genomic hybridization are prognostic markers in invasive ductal breast carcinomas. Histopathology 40: 547-555, 2002. (Pubitemid 34621813)
7. Miller BJ, Wang D, Krahe R and Wright FA: Pooled analysis of loss of heterozygosity in breast cancer: a genome scan provides comparative evidence for multiple tumor suppressors and identifies novel candidate regions. Am J Hum Genet 73: 748-767, 2003. (Pubitemid 37271880)
8. Zhao XJ, Li C, Paez JG, et al: An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays. Cancer Res 64: 3060-3071, 2004. (Pubitemid 38581405)
9. George RE, Attiyeh EF, Li SL, et al: Genome-wide analysis of neuroblastomas using high-density singlenucleotide polymorphism arrays. PLoS One 2: e255, 2007.
10. O'Keefe C, McDevitt MA and Maciejewski JP: Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies. Blood 115: 2731-2739, 2010.
11. Lim GC and Halimah Y: Second Report of the National Cancer Registry. Cancer Incidence in Malaysia 2003. National Cancer Registry. Kuala Lumpur, 2004.
12. Yip CH, Taib NA and Mohamed I: Epidemiology of breast cancer in Malaysia. Asian Pac J Cancer Prev 7: 369-374, 2006.
13. Argos M, Kibriya MG, Jasmine F, et al: Genomewide scan for loss of heterozygosity and chromosomal amplification in breast carcinoma using single-nucleotide polymorphism arrays. Cancer Genet Cytogenet 182: 69-74, 2008. (Pubitemid 351491323)
14. Haverty PM, Fridlyand J, Li L, et al: High-resolution genomic and expression analyses of copy number alterations in breast tumors. Genes Chromosomes Cancer 47: 530-542, 2008. (Pubitemid 351657188)
15. Hawthorn L, Luce J, Stein L and Rothschild J: Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast. BMC Cancer 10: 460, 2010.
16. Loo LWM, Ton C, Wang YW, et al: Differential patterns of allelic loss in estrogen receptor-positive infiltrating lobular and ductal breast cancer. Genes Chromosomes Cancer 47: 1049-1066, 2008.
17. Diskin SJ, Li MY, Hou CP, et al: Adjustment of genomic waves in signal intensities from whole-genome SNP genotyping platforms. Nucleic Acids Res 36: e126, 2008.
18. Chin SF, Teschendorff AE, Marioni JC, et al: High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer. Genome Biol 8: R215, 2007.
19. Kallioniemi A, Kallioniemi OP, Piper J, et al: Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci USA 91: 2156-2160, 1994. (Pubitemid 24092062)
20. Tirkkonen M, Tanner M, Karhu R, Kallioniemi A, Isola J and Kallioniemi OP: Molecular cytogenetics of primary breast cancer by CGH. Genes Chromosomes Cancer 21: 177-184, 1998. (Pubitemid 28136434)
21. Natrajan R, Lambros MB, Rodriguez-Pinilla SM, et al: Tiling path genomic profiling of grade 3 invasive ductal breast cancers. Clin Cancer Res 15: 2711-2722, 2009.
22. Ghaffari SR, Sabokbar T, Pour PN, et al: Comparative genomic hybridization (CGH) analysis of chromosomal aberrations in Iranian patients with invasive ductal carcinoma breast cancer. Asian Pac J Cancer Prev 9: 66-70, 2008.
23. Tsuji K, Kawauchi S, Saito S, et al: Breast cancer cell lines carry cell line-specific genomic alterations that are distinct from aberrations in breast cancer tissues: comparison of the CGH profiles between cancer cell lines and primary cancer tissues. BMC Cancer 10: 15, 2010.
24. Deming SL, Nass SJ, Dickson RB and Trock BJ: C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance. Br J Cancer 83: 1688-1695, 2000. (Pubitemid 32001715)
25. Guan YH, Kuo WL, Stilwell JL, et al: Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer. Clin Cancer Res 13: 5745-5755, 2007. (Pubitemid 47583899)
26. Valladares A, Salamanca F, Madrigal-Bujaidar E and Arenas D: Identification of chromosomal changes with comparative genomic hybridization in sporadic breast cancer in Mexican women. Cancer Genet Cytogenet 152: 163-166, 2004. (Pubitemid 38953022)
27. Saito S, Morita K and Hirano T: High frequency of common DNA copy number abnormalities detected by bacterial artificial chromosome array comparative genomic hybridization in 24 breast cancer cell lines. Hum Cell 22: 1-10, 2009.
28. Kao J, Salari K, Bocanegra M, et al: Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. PLoS One 4: e6146, 2009.
29. Bae JS, Choi JS, Baik SH, et al: Genomic alterations of primary tumor and blood in invasive ductal carcinoma of breast. World J Surg Oncol 8: 32, 2010.
30. Li J, Gromov P, Gromova I, et al: Omics-based profiling of carcinoma of the breast and matched regional lymph node metastasis. Proteomics 8: 5038-5052, 2008.
31. Naylor TL, Greshock J, Wang Y, et al: High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization. Breast Cancer Res 7: R1186-R1198, 2005.
32. Santarosa M and Ashworth A: Haploinsufficiency for tumour suppressor genes: when you don't need to go all the way. Biochim Biophys Acta 1654: 105-122, 2004. (Pubitemid 38681204)
33. Magee JA, Abdulkadir SA and Milbrandt J: Haploinsufficiency at the Nkx3.1 locus: a paradigm for stochastic, dosage-sensitive gene regulation during tumor initiation. Cancer Cell 3: 273-283, 2003. (Pubitemid 37443882)
34. Holmes KA, Song JS, Liu XLS, Brown M and Carroll JS: Nkx3-1 and LEF-1 function as transcriptional inhibitors of estrogen receptor activity. Cancer Res 68: 7380-7385, 2008.
35. Armes JE, Hammet F, de Silva M, et al: Candidate tumor-suppressor genes on chromosome arm 8p in early-onset and high-grade breast cancers. Oncogene 23: 5697-5702, 2004. (Pubitemid 39093049)
36. Chin K, DeVries S, Fridlyand J, et al: Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 10: 529-541, 2006. (Pubitemid 44854748)
37. Richard F, Pacyna-Gengelbach M, Schlüns K, et al: Patterns of chromosomal imbalances in invasive breast cancer. Int J Cancer 89: 305-310, 2000. (Pubitemid 30430749)
38. Chen CS, Zhou ZM, Ross JS, Zhou W and Dong JT: The amplified WWP1 gene is a potential molecular target in breast cancer. Int J Cancer 121: 80-87, 2007. (Pubitemid 46753854)
39. Heinrich C, Keller C, Boulay A, et al: Copine-III interacts with ErbB2 and promotes tumor cell migration. Oncogene 29: 1598-1610, 2010.
40. Rakha EA, Green AR, Powe DG, Roylance R and Ellis IO: Chromosome 16 tumor-suppressor genes in breast cancer. Genes Chromosomes Cancer 45: 527-535, 2006. (Pubitemid 43727159)
41. Dahiya R Perinchery G, Deng GR and Lee C: Multiple sites of loss of heterozygosity on chromosome 8 in human breast cancer has differential correlation with clinical parameters. Int J Oncol 12: 811-816, 1998.
42. Chua YL, Ito Y, Pole JCM, et al: The NRG1 gene is frequently silenced by methylation in breast cancers and is a strong candidate for the 8p tumour suppressor gene. Oncogene 28: 4041-4052, 2009.
43. Bhattacharya N, Chunder N, Basu D, et al: Three discrete areas within the chromosomal 8p21.3-23 region are associated with the development of breast carcinoma of Indian patients. Exp Mol Pathol 76: 264-271, 2004. (Pubitemid 38569789)
44. Wang Y, Li JS, Cui Y, et al: CMTM3, located at the critical tumor suppressor locus 16q22.1, is silenced by CpG methylation in carcinomas and inhibits tumor cell growth through inducing apoptosis. Cancer Res 69: 5194-5201, 2009.
45. Phelan CM, Borg A, Cuny M, et al: Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters. Cancer Res 58: 1004-1012, 1998. (Pubitemid 28182471)
46. Phillips N, Ziegler M, Saha B and Xynos F: Allelic loss on chromosome 17 in human ovarian cancer. Int J Cancer 54: 85-91, 1993. (Pubitemid 23137004)
47. Simard J, Dumont M, Labuda D, et al: Prostate cancer susceptibility genes: lessons learned and challenges posed. Endocr Relat Cancer 10: 225-259, 2003. (Pubitemid 36763535)
48. Roncuzzi L, Brognara I, Cocchi S, Zoli W and Gasperi-Campani A: Loss of heterozygosity at pseudoautosomal regions in human breast cancer and association with negative hormonal phenotype. Cancer Genet Cytogenet 135: 173-176, 2002. (Pubitemid 34786769)
49. Xu JF, Meyers D, Freije D, et al: Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat Genet 20: 175-179, 1998. (Pubitemid 28455451)
50. Loupart ML, Adams S, Armour JAL, Walker R, Brammar W and Varley J: Loss of heterozygosity on the X-chromosome in human breast cancer. Genes Chromosomes Cancer 13: 229-238, 1995.
51. Tuna M, Knuutila S and Mills GB: Uniparental disomy in cancer. Trends Mol Med 15: 120-128, 2009.
52. Lin X, Duan XY, Liang YY, et al: PPMlA functions as a Smad phosphatase to terminate TGF beta signaling. Cell 125: 915-928, 2006. (Pubitemid 43795197)
53. Feng W, Orlandi R, Zhao N, et al: Tumor suppressor genes are frequently methylated in lymph node metastases of breast cancers. BMC Cancer 10: 378, 2010.
54. Shivakumar L, Minna J, Sakamaki T, Pestell R and White MA: The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Mol Cell Biol 22: 4309-4318, 2002. (Pubitemid 34556598)
55. Richardson AL, Wang ZGC, De Nicolo A, et al: X chromosomal abnormalities in basal-like human breast cancer. Cancer Cell 9: 121-132, 2006. (Pubitemid 43202662)